Modified Suanzaorentang Had the Treatment Effect for Generalized Anxiety Disorder for the First 4 Weeks of Paroxetine Medication: A Pragmatic Randomized Controlled Study
Open Access
- 1 January 2017
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2017 (1) , 8391637
Abstract
Background. Paroxetine does not show satisfactory therapeutic effect for generalized anxiety disorder (GAD) patients for the first 2–4 weeks of medication. Diazepam is always concurrently used although it has some shortcomings such as physical dependence and withdrawal reactions. In this study, we aimed to identify whether modified Suanzaorentang (MSZRT), a combined Chinese formula including Suanzaorentang (SZRT) and Zhizichitang (ZZCT), could control the anxiety of GAD for the first 4 weeks of paroxetine medication. Methods. 156 GAD patients were randomized to the treatment of paroxetine, paroxetine‐diazepam, or paroxetine‐MSZRT for 4 weeks. Hamilton Anxiety Scale (HAMA) Test and Self‐Rating Anxiety Scale (SAS) Test were determined each week as the evaluation of clinical efficacy. Adverse events (AEs) were also closely observed by performing the Treatment Emergent Symptom Scale (TESS) Test. Results. Both paroxetine‐MSZRT and paroxetine‐diazepam decreased more HAMA and SAS total scores than paroxetine from weeks 1 to 3. Paroxetine‐MSZRT as well as paroxetine‐diazepam had an obviously higher onset rate than paroxetine in each week. After 4 weeks’ treatment, the overall effectiveness rate in the paroxetine‐MSZRT group (90.00%) was obviously higher than those of the paroxetine group (74.42%) but did not significantly differ from the paroxetine‐diazepam group (93.88%). Conclusion. MSZRT had the treatment effect for GAD when paroxetine was used for the first 4 weeks.Keywords
Funding Information
- National Natural Science Foundation of China (20140733Q49, 81601183, 20160533B28)
This publication has 33 references indexed in Scilit:
- Observational Studies on Evaluating the Safety and Adverse Effects of Traditional Chinese MedicineEvidence-Based Complementary and Alternative Medicine, 2013
- Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2012
- Characterization of 5-HT1A/1B−/− mice: An animal model sensitive to anxiolytic treatmentsNeuropharmacology, 2011
- Plasticity of Presynaptic and Postsynaptic Serotonin 1A Receptors in an Animal Model of Epilepsy-Associated DepressionNeuropsychopharmacology, 2011
- Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disordersExpert Review of Neurotherapeutics, 2009
- 5-HT1A receptor function in major depressive disorderProgress in Neurobiology, 2009
- The involvement of serotonin receptors in suanzaorentang-induced sleep alterationJournal of Biomedical Science, 2007
- Gamma-aminobutyric acid (GABA) receptor mediates suanzaorentang, a traditional Chinese herb remedy, -induced sleep alterationJournal of Biomedical Science, 2006
- Selective Serotonin Reuptake Inhibitor Treatment for Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2005
- Pragmatic clinical trialsComplementary Therapies in Medicine, 2004